George Sourvinos
Overview
Explore the profile of George Sourvinos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
86
Citations
1200
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alexakis K, Ioannou P, Sourvinos G, Kofteridis D
Germs
. 2025 Jan;
14(3):267-276.
PMID: 39776960
Introduction: Central nervous system (CNS) infection due to the varicella zoster virus (VZV) can complicate the primary infection or the reactivation, leading to significant mortality and morbidity. This study aimed...
2.
Botha J, Zafilaza K, Soulie C, Yin N, Spyer M, Balaska S, et al.
Microbiol Spectr
. 2024 Oct;
:e0067224.
PMID: 39422469
The goal of this study is to test a novel device and methodology based on the "Pebble" platform and real-time quantitative colorimetric loop-mediated isothermal amplification (qcLAMP) during SARS-CoV-2 detection using...
3.
Leruez-Ville M, Chatzakis C, Lilleri D, Blazquez-Gamero D, Alarcon A, Bourgon N, et al.
Lancet Reg Health Eur
. 2024 Jul;
42:100974.
PMID: 39050231
[This corrects the article DOI: 10.1016/j.lanepe.2024.100892.].
4.
Leruez-Ville M, Chatzakis C, Lilleri D, Blazquez-Gamero D, Alarcon A, Bourgon N, et al.
Lancet Reg Health Eur
. 2024 Apr;
40:100892.
PMID: 38590940
Congenital cytomegalovirus (cCMV) infection carries a significant burden with a 0.64% global prevalence and a 17-20% chance of serious long-term effects in children. Since the last guidelines, our understanding, particularly...
5.
Lionis C, Petelos E, Linardakis M, Diamantakis A, Symvoulakis E, Karkana M, et al.
Diseases
. 2023 Aug;
11(3).
PMID: 37606476
Introduction: The need for effective therapeutic regimens for non-critically ill patients during the COVID-19 pandemic remained largely unmet. Previous work has shown that a combination of three aromatic plants' essential...
6.
Mellou K, Tryfinopoulou K, Emmanouil M, Gkolfinopoulou K, Sapounas S, Evangelidou M, et al.
Euro Surveill
. 2023 Jul;
28(28).
PMID: 37440348
After the near absence of influenza and other respiratory viruses during the first 2 years of the COVID-19 pandemic, an increased activity of mainly influenza A(H3N2) was detected at the...
7.
Mellou K, Tryfinopoulou K, Pappa S, Gkolfinopoulou K, Papanikou S, Papadopoulou G, et al.
Viruses
. 2023 Jun;
15(6).
PMID: 37376683
In May 2022, for the first time, multiple cases of mpox were reported in several non-endemic countries. The first ever case of the disease in Greece was confirmed on 8...
8.
Eptaminitaki G, Parakatselaki M, Petroulaki C, Marinopoulou D, Pitsikaki A, Tseliou M, et al.
J Virol Methods
. 2023 May;
319:114759.
PMID: 37257757
The circulation of certain SARS-CoV-2 variants may have a great impact on the epidemiological status of a geographical area; therefore, it is important that their presence is monitored. Currently, the...
9.
Zafiropoulos A, Dermitzaki A, Malliarakis N, Stamataki M, Ergazaki M, Xenaki E, et al.
Infect Dis (Lond)
. 2023 May;
55(7):509-513.
PMID: 37198922
Background: Rapid and accurate diagnostics of patients with suspected seasonal influenza or pathogens of the upper respiratory tract is crucial. Fast detection is important especially for influenza A/B virus, so...
10.
Ioannou P, Katsigiannis A, Papakitsou I, Kopidakis I, Makraki E, Milonas D, et al.
Viruses
. 2023 Mar;
15(3).
PMID: 36992465
Patients receiving treatment with B-cell-depleting monoclonal antibodies, such as anti-CD20 monoclonal antibodies, such as rituximab and obinutuzumab, either for hematological disease or another diagnosis, such as a rheumatological disease, are...